[go: up one dir, main page]

CY1113725T1 - Monoclonal antibodies bound to HGM-CSF and the pharmaceutical compositions containing them - Google Patents

Monoclonal antibodies bound to HGM-CSF and the pharmaceutical compositions containing them

Info

Publication number
CY1113725T1
CY1113725T1 CY20131100180T CY131100180T CY1113725T1 CY 1113725 T1 CY1113725 T1 CY 1113725T1 CY 20131100180 T CY20131100180 T CY 20131100180T CY 131100180 T CY131100180 T CY 131100180T CY 1113725 T1 CY1113725 T1 CY 1113725T1
Authority
CY
Cyprus
Prior art keywords
hgm
csf
pharmaceutical compositions
monoclonal antibodies
compositions containing
Prior art date
Application number
CY20131100180T
Other languages
Greek (el)
Inventor
Kenzo Takada
Kantou Nakajima
Barbara Kistler
John Park
Original Assignee
Evec Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP08848696A external-priority patent/EP2215119B1/en
Application filed by Evec Inc. filed Critical Evec Inc.
Publication of CY1113725T1 publication Critical patent/CY1113725T1/en

Links

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Γνωστοποιούνται στο παρόν αντι-hGM-CSF μονόκλωνα αντισώματα και αντιγονο-δεσμευτικά θραύσματα τέτοιων αντισωμάτων, με βελτιωμένη εξουδετερωτική ικανότητα σε hGM-CSF δραστικότητα. Φαρμακευτικές συνθέσεις οι οποίες περιλαμβάνουν ένα τέτοιο αντίσωμα ή αντιγονο-δεσμευτικό θραύσμα επίσης παρέχονται. Η παρούσα εφεύρεση είναι χρήσιμη για την αντιμετώπιση διαφόρων νόσων οι οποίες συνδέονται με ανώμαλη έκφραση hGM-CSF.Anti-hGM-CSF monoclonal antibodies and antigen-binding fragments of such antibodies are disclosed herein, with improved neutralizing ability in hGM-CSF activity. Pharmaceutical compositions comprising such an antibody or antigen-binding fragment are also provided. The present invention is useful in treating various diseases associated with abnormal hGM-CSF expression.

CY20131100180T 2007-11-13 2013-02-27 Monoclonal antibodies bound to HGM-CSF and the pharmaceutical compositions containing them CY1113725T1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2007294945 2007-11-13
EP08848696A EP2215119B1 (en) 2007-11-13 2008-11-12 Monoclonal antibodies that bind to hgm-csf and medical compositions comprising same

Publications (1)

Publication Number Publication Date
CY1113725T1 true CY1113725T1 (en) 2016-06-22

Family

ID=51948955

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20131100180T CY1113725T1 (en) 2007-11-13 2013-02-27 Monoclonal antibodies bound to HGM-CSF and the pharmaceutical compositions containing them

Country Status (2)

Country Link
CY (1) CY1113725T1 (en)
UA (1) UA102085C2 (en)

Also Published As

Publication number Publication date
UA102085C2 (en) 2013-06-10

Similar Documents

Publication Publication Date Title
CY1120626T1 (en) ANTIBODIES AND OTHER MOLECULES BIND B7-H1 AND PD-1
CY1119454T1 (en) ANTIBODIES AGAINST CD38 FOR TREATMENT OF MULTIPLE MYELOMA
CY1123028T1 (en) FIXED AND SOLUBLE VEGF-INHIBITING ANTIBODIES
CY1116886T1 (en) C-MET ACCESSORIES
CY1114271T1 (en) CLEANINGS, HUMAN CELLULAR PUMP, AND USE OF THESE
CY1119445T1 (en) ANTIBODIES AGAINST HUMAN GDF8
CY1122490T1 (en) ANTIBODIES TO HUMAN CD38
CY1120096T1 (en) RECOGNITION OF VOLUME ANTIGENS RELATED TO DIAGNOSIS AND TREATMENT
CY1120065T1 (en) HUMAN ANTIBODIES FOR TON ERBB 2
CY1121648T1 (en) HUMAN MONOCLONAL ANTIBODIES TO PROGRAMMED DEATH l(PD-1) AND METHODS OF TREATING CANCER USING ANTI-PD-1 ANTIBODIES ALONE OR IN COMBINATION WITH OTHER IMMUNOTHERAPEUTICS
CY1119994T1 (en) COMPOSITIONS AND METHODS FOR INCREASING MUSCLE AND MUSCLE POWER COMPETITIVE SPECIFICALLY TON GDF8 AND / OR ACTIVITY
CY1124412T1 (en) ANTI-DKK-1 ANTIBODIES
CY1122091T1 (en) CD37-BINDING MOLECULES AND IMMUNOCONJUGUES THEREOF
CY1124437T1 (en) HUMAN ANTIBODIES AGAINST PD-L1
CY1120665T1 (en) HUMANIZED ANTI-CXCR5 ANTIBODIES, DERIVATIVES OF THEM AND THEIR USES
CY1120359T1 (en) STABLE PHARMACEUTICAL FORMS OF ANTIBODIES AGAINST HUMAN RELIABLE PD-1 RECEPTION DEATH AND RELATED TREATMENTS
CY1120412T1 (en) ILL-31 SPECIALIZED PARTICULAR PARTS
CY1117563T1 (en) HER3 PARTS AND USE OF THESE
CY1125102T1 (en) ANTIGEN-BINDING PROTEINS THAT ACTIVATE THE LEPTIN RECEPTOR
CY1115572T1 (en) CXCR4 ANTIBODIES AND USE OF THESE FOR CANCER TREATMENT
CY1118977T1 (en) HARDNESS AREAS
TN2010000210A1 (en) Monoclonal antibodies that bind to hgm-csf and medical compositions comprising same
CY1118053T1 (en) MEDICINAL COMPOSITIONS WITH RESOLUTION IN CEA SOLUTION
CY1119410T1 (en) OPTIMIZED monoclonal antibodies against the TFPI inhibitor (TFPI)
CY1117859T1 (en) ANTI-CD79B ANTIBODIES AND IMMUNIZATIONS AND METHODS OF USE